Sarclisa

NDC 0024-0654 · Sanofi-Aventis U.S. LLC

Generic nameisatuximab

Dosage formINJECTION, SOLUTION, CONCENTRATE

RouteINTRAVENOUS

Active ingredient(s)ISATUXIMAB

Strength100 mg/5mL

Pharmacologic classAntibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]

Marketing categoryBLA

Packages

0024-0654-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0024-0654-01) / 5 mL in 1 VIAL, SINGLE-DOSE

J9227 — Injection, isatuximab-irfc, 10 mg Medicare Part B payment limit (ASP + 6%): $88.16

FDA lists these products with the same active ingredient.

0024-0656 — isatuximab, 0024-0674 — isatuximab-irfc

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.